Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Gross Profit : $0.00 Mil (TTM As of Jan. 2020)

Cotinga Pharmaceuticals Gross Profit Chart

Cotinga Pharmaceuticals Annual Data
	Trend	Apr10	Apr11	Apr12	Apr13	Apr14	Apr15	Apr16	Apr17	Apr18	Apr19
Gross Profit		Get a 7-Day Free Trial					-	-	-	-	-

Cotinga Pharmaceuticals Quarterly Data
	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20
Gross Profit	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cotinga Pharmaceuticals's Gross Profit

For the Biotechnology subindustry, Cotinga Pharmaceuticals's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cotinga Pharmaceuticals's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cotinga Pharmaceuticals's Gross Profit distribution charts can be found below:

* The bar in red indicates where Cotinga Pharmaceuticals's Gross Profit falls into.

Cotinga Pharmaceuticals Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Cotinga Pharmaceuticals's Gross Profit for the fiscal year that ended in Apr. 2019 is calculated as

Cotinga Pharmaceuticals's Gross Profit for the quarter that ended in Jan. 2020 is calculated as

Gross Profit for the trailing twelve months (TTM) ended in Jan. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Cotinga Pharmaceuticals's Gross Margin % for the quarter that ended in Jan. 2020 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Cotinga Pharmaceuticals  (OTCPK:COTQF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cotinga Pharmaceuticals had a gross margin of N/A% for the quarter that ended in Jan. 2020 => No sustainable competitive advantage

Cotinga Pharmaceuticals Gross Profit Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Business Description